A single targeted mutation known as R126E has proven capable of enhancing the potency of growth-promoting proteins while making them more resistant to chemical degradation. This finding comes at a time when regenerative medicine is seeking more durable solutions for patients with impaired healing
Standard laboratory protocols for washing and preparing harvested stem cells must be modified with pre-warmed solutions to prevent thermal shock in sensitive biological samples. This requirement becomes critically apparent when treating patients with Cold Agglutinin Disease (CAD), a rare autoimmune
Biopharmaceutical companies in France are utilizing disposable systems to remain competitive by shortening the downtime required between different product batches. This shift represents a fundamental realignment of industrial priorities, moving away from the rigid, permanent infrastructure of the
A record 383 vials of LYMPHIR were ordered in July, establishing a new performance benchmark for the company’s expanded 29-member nationwide sales infrastructure. This milestone represents a significant pivot for Citius Pharmaceuticals as it transitions from a clinical-stage entity into a
Evidence suggests that neuroinflammation in CAR T-cell patients can persist as a localized metabolic crisis even after systemic inflammatory markers in the bloodstream have been successfully reduced. This finding highlights the complex nature of Chimeric Antigen Receptor (CAR) T-cell therapy, a
Identifying CD31 protein expression in engineered tissue constructs serves as a vital indicator that a functional internal blood vessel network has begun to take shape. For patients grappling with catastrophic bone injuries or the aftermath of tumor removals, the quest for a permanent solution
